z-logo
open-access-imgOpen Access
A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
Author(s) -
Marco Demaria,
Carlotta Giorgi,
Magdalena Lebiedzińska,
Giovanna Esposito,
Luca D’Angeli,
A. Bartoli,
Daniel J. Gough,
James Turkson,
David E. Levy,
Christine J. Watson,
Mariusz R. Wiȩckowski,
Paolo Provero,
Paolo Pinton,
Valeria Poli
Publication year - 2010
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.100232
Subject(s) - stat3 , microbiology and biotechnology , glycolysis , biology , transcription factor , anaerobic glycolysis , mitochondrion , programmed cell death , cell growth , downregulation and upregulation , apoptosis , cancer research , signal transduction , biochemistry , metabolism , gene
The pro-oncogenic transcription factor STAT3 is constitutively activated in a wide variety of tumours that often become addicted to its activity, but no unifying view of a core function determining this widespread STAT3-dependence has yet emerged. We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down-regulating mitochondrial activity both in primary fibroblasts and in STAT3-dependent tumour cell lines. As a result, cells are protected from apoptosis and senescence while becoming highly sensitive to glucose deprivation. We show that enhanced glycolysis is dependent on HIF-1α up-regulation, while reduced mitochondrial activity is HIF-1α-independent and likely caused by STAT3-mediated down-regulation of mitochondrial proteins. The induction of aerobic glycolysis is an important component of STAT3 pro-oncogenic activities, since inhibition of STAT3 tyrosine phosphorylation in the tumour cell lines down-regulates glycolysis prior to leading to growth arrest and cell death, both in vitro and in vivo. We propose that this novel, central metabolic role is at the core of the addiction for STAT3 shown by so many biologically different tumours.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom